A systematic review and economic model of the effectiveness and ...

189. Francis S, Fine J, Tannock R. Methylphenidate
selectively improves story retelling in children with
attention deficit hyperactivity disorder. J Child
Adolesc Psychopharmacol 2001;11:217–28.
190. Gadow KD, Nolan E, Sverd J, Sprafkin J,
Paolicelli L. Methylphenidate in aggressivehyperactive
boys: I. Effects on peer aggression in
public school settings. J Am Acad Child Adolesc
Psychiatry 1990;29:710–18.
191. Gadow KD, Sverd J, Sprafkin J, Nolan EE,
Grossman S. Long-term methylphenidate therapy
in children with comorbid attention-deficit
hyperactivity disorder and chronic multiple tic
disorder. Arch Gen Psychiatry 1999;56:330–6.
192. Gadow KD, Nolan EE, Sverd J, Sprafkin J,
Schwartz J. Anxiety and depression symptoms and
response to methylphenidate in children with
attention-deficit hyperactivity disorder and tic
disorder. J Clin Psychopharmacol 2002;22:267–74.
193. Goldberg J. Clonidine and methylphenidate were
effective for attention deficit hyperactivity disorder
in children with comorbid tics. Evid Based Ment
Health 2002;5:122.
194. Goldberg J. Clonidine and methylphenidate were
effective for attention deficit hyperactivity disorder
in children with comorbid tics. ACP J Club
2002;137:70.
195. Grcevich S. Review: Adderall may have a small
advantage over methylphenidate in attention
deficit hyperactivity disorder. Evid Based Ment
Health 2003;6:43.
196. Greenhill LL. Efficacy and safety of once-daily
methylphenidate HCl, standard methylphenidate
and placebo in children with ADHD. In 153rd
Annual Meeting of the American Psychiatric Association,
13–18 May 2002, Chicago, IL.
197. Greenhill LL. Evaluation of the efficacy and safety
of Concerta (methylphenidate HCl) extendedrelease
tablets, ritalin, and placebo in children
with ADHD. Neurology 2000;54 (suppl 7):A420–1.
198. Greenhill LL, Halperin JM, Abikof H. Stimulant
medications. J Am Acad Child Adolesc Psychiatry
1999;38:503–12.
199. Greenhill LL, Pliszka S, Dulcan MK, Bernet W,
Arnold V, Beitchman J, et al. Practice parameter
for the use of stimulant medications in the
treatment of children, adolescents, and adults.
J Am Acad Child Adolesc Psychiatry 2002;41
(2 Suppl):26S–49S.
200. Gross-Tsur V, Shalev RS, Badihi N, Manor O.
Efficacy of methylphenidate in patients with
cerebral palsy and attention-deficit hyperactivity
disorder (ADHD). J Child Neurol 2002;17:863–6.
201. Handen BL, Johnson CR, Lubetsky M. Efficacy of
methylphenidate among children with autism and
© Queen’s Printer and Controller of HMSO 2006. All rights reserved.
Health Technology Assessment 2006; Vol. 10: No. 23
symptoms of attention-deficit hyperactivity
disorder. J Autism Dev Disord 2000;30:245–55.
202. Heiligenstein JH, Biederman J, Christopher J,
Galil N, West Scott A, Emslie Graham J. Efficacy of
tomoxetine versus placebo in school-age girls with
ADHD. In 155th Annual Meeting of the American
Psychiatric Association, 18–23 May 2002;
Philadelphia, PA.
203. Heiligenstein JH, Biederman J, Kratochvil CJ,
Galil N, West SA, Emslie GJ. Efficacy of
tomoxetine versus placebo in school-age girls with
ADHD. In Annual Meeting of the American Psychiatric
Association 5–10 May 2001, New Orleans, LA.
204. Heiligenstein JH, Dunn DW, Busner J, Stein M,
McDougle CJ. Efficacy of tomoxetine versus
placebo in school-age children with ADHD who
failed psychostimulant treatment. In Annual
Meeting of the American Psychiatric Association
5–10 May 2001, New Orleans, LA.
205. Heiligenstein JH, Wagner KD, Casat CD, Busner J,
Newcorn JH, Saylor KE, et al. Efficacy of
tomoxetine versus placebo in school-age children
with ADHD: inattentive subtype. In Annual Meeting
of the American Psychiatric Association 5–10 May
2001, New Orleans, LA.
206. Hoffman M, Pelham WE, Burrows-MacLean L.
Dose-ranging studies demonstrating efficacy of
once-daily transdermal methylphenidate, timecourse
of action, and effect in combination with
behavioral modification in pediatric patients with
ADHD. Pediatr Res 2003;53:556A.
207. Jadad AR, Boyle M, Cunningham C.
Pharmacological interventions are more effective
than non-pharmacological for attention deficit
hyperactivity disorder. Evid Based Med 2000;5:179.
208. Kent MA, Camfield CS, Camfield PR. Doubleblind
methylphenidate trials – practical, useful,
and highly endorsed by families. Arch Pediatr
Adolesc Med 1999;153:1292–6.
209. Klein C, Fischer B, Fischer B, Hartnegg K. Effects
of methylphenidate on saccadic responses in
patients with ADHD. Exp Brain Res
2002;145:121–5.
210. Kollins SH, MacDonald EK, Rush CR. Assessing
the abuse potential of methylphenidate in
nonhuman and human subjects: a review.
Pharmacol Biochem Behav 2001;68:611–27.
211. Konrad K, Gunther T, Hanisch C,
Herpertz-Dahlmann B. Differential effects of
methylphenidate on attentional functions in
children with attention-deficit/hyperactivity
disorder. J Am Acad Child Adolesc Psychiatry
2004;43:191–8.
212. Kurlan R, Goldberg J. Clonidine and
methylphenidate were effective for attention
deficit hyperactivity disorder in children with
comorbid tics. Evid Based Med 2002;7:157.
141